401 related articles for article (PubMed ID: 34762363)
1. Atorvastatin does not ameliorate nephrogenic diabetes insipidus induced by lithium or potassium depletion in mice.
Thomsen ML; Grønkjaer C; Iervolino A; Rej S; Trepiccione F; Christensen BM
Physiol Rep; 2021 Nov; 9(21):e15111. PubMed ID: 34762363
[TBL] [Abstract][Full Text] [Related]
2. Atorvastatin in the treatment of Lithium-induced nephrogenic diabetes insipidus: the protocol of a randomized controlled trial.
Fotso Soh J; Torres-Platas SG; Beaulieu S; Mantere O; Platt R; Mucsi I; Saury S; Renaud S; Levinson A; Andreazza AC; Mulsant BH; Müller D; Schaffer A; Dols A; Cervantes P; Low NC; Herrmann N; Christensen BM; Trepiccione F; Rajji T; Rej S
BMC Psychiatry; 2018 Jul; 18(1):227. PubMed ID: 30012135
[TBL] [Abstract][Full Text] [Related]
3. Aldosterone increases urine production and decreases apical AQP2 expression in rats with diabetes insipidus.
Nielsen J; Kwon TH; Praetorius J; Frøkiaer J; Knepper MA; Nielsen S
Am J Physiol Renal Physiol; 2006 Feb; 290(2):F438-49. PubMed ID: 16159898
[TBL] [Abstract][Full Text] [Related]
4. Hydrochlorothiazide attenuates lithium-induced nephrogenic diabetes insipidus independently of the sodium-chloride cotransporter.
Sinke AP; Kortenoeven ML; de Groot T; Baumgarten R; Devuyst O; Wetzels JF; Loffing J; Deen PM
Am J Physiol Renal Physiol; 2014 Mar; 306(5):F525-33. PubMed ID: 24352504
[TBL] [Abstract][Full Text] [Related]
5. Lithium-induced NDI: acetazolamide reduces polyuria but does not improve urine concentrating ability.
de Groot T; Doornebal J; Christensen BM; Cockx S; Sinke AP; Baumgarten R; Bedford JJ; Walker RJ; Wetzels JFM; Deen PMT
Am J Physiol Renal Physiol; 2017 Sep; 313(3):F669-F676. PubMed ID: 28615247
[TBL] [Abstract][Full Text] [Related]
6. Role of adenylyl cyclase 6 in the development of lithium-induced nephrogenic diabetes insipidus.
Poulsen SB; Kristensen TB; Brooks HL; Kohan DE; Rieg T; Fenton RA
JCI Insight; 2017 Apr; 2(7):e91042. PubMed ID: 28405619
[TBL] [Abstract][Full Text] [Related]
7. Altered expression of renal AQPs and Na(+) transporters in rats with lithium-induced NDI.
Kwon TH; Laursen UH; Marples D; Maunsbach AB; Knepper MA; Frokiaer J; Nielsen S
Am J Physiol Renal Physiol; 2000 Sep; 279(3):F552-64. PubMed ID: 10966935
[TBL] [Abstract][Full Text] [Related]
8. Lithium induces aerobic glycolysis and glutaminolysis in collecting duct principal cells.
Alsady M; de Groot T; Kortenoeven MLA; Carmone C; Neijman K; Bekkenkamp-Grovenstein M; Engelke U; Wevers R; Baumgarten R; Korstanje R; Deen PMT
Am J Physiol Renal Physiol; 2018 Feb; 314(2):F230-F239. PubMed ID: 29070571
[TBL] [Abstract][Full Text] [Related]
9. Development of lithium-induced nephrogenic diabetes insipidus is dissociated from adenylyl cyclase activity.
Li Y; Shaw S; Kamsteeg EJ; Vandewalle A; Deen PM
J Am Soc Nephrol; 2006 Apr; 17(4):1063-72. PubMed ID: 16495377
[TBL] [Abstract][Full Text] [Related]
10. Changes of rat kidney AQP2 and Na,K-ATPase mRNA expression in lithium-induced nephrogenic diabetes insipidus.
Laursen UH; Pihakaski-Maunsbach K; Kwon TH; Østergaard Jensen E; Nielsen S; Maunsbach AB
Nephron Exp Nephrol; 2004; 97(1):e1-16. PubMed ID: 15153756
[TBL] [Abstract][Full Text] [Related]
11. Combination of secretin and fluvastatin ameliorates the polyuria associated with X-linked nephrogenic diabetes insipidus in mice.
Procino G; Milano S; Carmosino M; Barbieri C; Nicoletti MC; Li JH; Wess J; Svelto M
Kidney Int; 2014 Jul; 86(1):127-38. PubMed ID: 24522493
[TBL] [Abstract][Full Text] [Related]
12. alphaENaC-mediated lithium absorption promotes nephrogenic diabetes insipidus.
Christensen BM; Zuber AM; Loffing J; Stehle JC; Deen PM; Rossier BC; Hummler E
J Am Soc Nephrol; 2011 Feb; 22(2):253-61. PubMed ID: 21051735
[TBL] [Abstract][Full Text] [Related]
13. Antidiuretic effect of hydrochlorothiazide in lithium-induced nephrogenic diabetes insipidus is associated with upregulation of aquaporin-2, Na-Cl co-transporter, and epithelial sodium channel.
Kim GH; Lee JW; Oh YK; Chang HR; Joo KW; Na KY; Earm JH; Knepper MA; Han JS
J Am Soc Nephrol; 2004 Nov; 15(11):2836-43. PubMed ID: 15504936
[TBL] [Abstract][Full Text] [Related]
14. Genetic deletion of ADP-activated P2Y
Zhang Y; Hansson KM; Liu T; Magnell K; Huang Y; Carlson NG; Kishore BK
Acta Physiol (Oxf); 2019 Feb; 225(2):e13191. PubMed ID: 30257062
[TBL] [Abstract][Full Text] [Related]
15. Tamoxifen attenuates development of lithium-induced nephrogenic diabetes insipidus in rats.
Tingskov SJ; Hu S; Frøkiær J; Kwon TH; Wang W; Nørregaard R
Am J Physiol Renal Physiol; 2018 May; 314(5):F1020-F1025. PubMed ID: 29357422
[TBL] [Abstract][Full Text] [Related]
16. Bile Acid G Protein-Coupled Membrane Receptor TGR5 Modulates Aquaporin 2-Mediated Water Homeostasis.
Li S; Qiu M; Kong Y; Zhao X; Choi HJ; Reich M; Bunkelman BH; Liu Q; Hu S; Han M; Xie H; Rosenberg AZ; Keitel V; Kwon TH; Levi M; Li C; Wang W
J Am Soc Nephrol; 2018 Nov; 29(11):2658-2670. PubMed ID: 30305310
[TBL] [Abstract][Full Text] [Related]
17. Absence of PKC-alpha attenuates lithium-induced nephrogenic diabetes insipidus.
Sim JH; Himmel NJ; Redd SK; Pulous FE; Rogers RT; Black LN; Hong SM; von Bergen TN; Blount MA
PLoS One; 2014; 9(7):e101753. PubMed ID: 25006961
[TBL] [Abstract][Full Text] [Related]
18. Genetic Deletion of P2Y
Zhang Y; Riquier-Brison A; Liu T; Huang Y; Carlson NG; Peti-Peterdi J; Kishore BK
Front Physiol; 2018; 9():1765. PubMed ID: 30618788
[TBL] [Abstract][Full Text] [Related]
19. 4-PBA improves lithium-induced nephrogenic diabetes insipidus by attenuating ER stress.
Zheng P; Lin Y; Wang F; Luo R; Zhang T; Hu S; Feng P; Liang X; Li C; Wang W
Am J Physiol Renal Physiol; 2016 Oct; 311(4):F763-F776. PubMed ID: 27385737
[TBL] [Abstract][Full Text] [Related]
20. Aliskiren increases aquaporin-2 expression and attenuates lithium-induced nephrogenic diabetes insipidus.
Lin Y; Zhang T; Feng P; Qiu M; Liu Q; Li S; Zheng P; Kong Y; Levi M; Li C; Wang W
Am J Physiol Renal Physiol; 2017 Oct; 313(4):F914-F925. PubMed ID: 28228402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
